Burns Matteson Capital Management’s Pfizer PFE Stock Holding History

Burns Matteson Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$490K	Buy	+20,337	New	+$532K	0.15%	115
2023 Q4	–	Sell	-16,191	Closed	-$537K	–	166
2023 Q3	$537K	Buy	+16,191	New	+$573K	0.34%	87
2023 Q2	–	Sell	-12,661	Closed	-$517K	–	174
2023 Q1	$517K	Sell	12,661 -339	-3%	-$14.6K	0.33%	90
2022 Q4	$666K	Buy	+13,000	New	+$623K	0.44%	57

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Burns Matteson Capital Management's PFE Position: Q2 2026 in Review

Burns Matteson Capital Management opened a new position in Pfizer (PFE) in Q2 2026: 20,337 shares worth $490K. The stake represents 0.15% of the portfolio and ranks #115 among its holdings. This is a return to the name: Burns Matteson Capital Management previously reported a position in PFE as recently as Q3 2023.

Burns Matteson Capital Management first reported a position in PFE in Q4 2022 and has held it in 4 quarters since. The position peaked at $666K in Q4 2022. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Burns Matteson Capital Management held 20,337 shares of Pfizer worth $490K as of Q2 2026.
Pfizer was a new Burns Matteson Capital Management position in Q2 2026.
Pfizer made up 0.15% of Burns Matteson Capital Management's portfolio in Q2 2026, its #115 holding.
Burns Matteson Capital Management first reported a position in Pfizer in Q4 2022 and has held it in 4 quarters since.
Burns Matteson Capital Management's Pfizer position peaked at $666K in Q4 2022.
557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.